F L Iii Garrett

F L Iii Garrett (Director) bought 1,300 shares at blended $14.57 over 5 days; stock up 16.0% in 90 days; 2 other insiders also bought recently.

F L Iii Garrett, a Director at Primis Financial Corp., executed 5 separate purchases totaling 1,300 shares for $18,935.63 between June 1–5, 2026, at prices ranging from $14.30 to $15.00. His holdings increased 2.8% to 47,934 shares post-transaction. The stock has appreciated 16.0% over the past 90 days and currently trades at $15.04, within 0.9% of its 52-week high of $15.18. Notably, his 5 prior purchases at FRST were all well-timed at the 90-day mark, with average 90-day returns of 4.2% per prior trade. A cluster pattern is present: 2 other insiders also bought within the past 14 days, suggesting synchronized buying interest at this price level.

Director F L Iii Garrett bought 1,394 shares at FRST over 5 days (avg $14.46); 0 of 3 prior same-ticker buys were well-timed at 90 days.

F L Iii Garrett executed 5 separate purchases totaling 1,394 shares for $20,156.51 between May 22–29, 2026, increasing his holdings by 3.1% to 46,634 shares. The blended average price was $14.46, slightly above the current price of $14.36 and near the 52-week high of $14.97. Examining his prior trades at Primis, Garrett's three prior same-ticker buys show inconsistent timing: the 2025 purchases posted modest 30-day gains (+0.9% and +2.1%) but turned negative by 90 days (-2.8% and -2.6%), while the December 2024 buy was deeply underwater at both horizons (-14.1% at 30 days, -20.2% at 90 days). Across all tickers and all open-market history, his track record shows 0 of 3 prior buys were well-timed at the 90-day mark, with an average 90-day return of -8.5%. The current purchase near the 52-week high and just -2.3% from the 30-day mark, combined with this historical pattern of post-purchase declines, offers limited reassurance on timing accuracy.

Director Garrett F L III purchases 2,261 shares of FRST at $11.07 on 2025-08-06, increasing holdings to 45,240 shares.

Garrett F L III, a director, purchased 2,261 shares at $11.07 on 2025-08-06, expanding his position by 5.3% to 45,240 shares total. The company trades at a P/E of 68.88 and reported negative full-year net income, suggesting elevated valuation relative to current earnings power. The director's prior purchase at this same ticker on 2024-12-13 delivered a 90-day return of -20.2%, and his cross-ticker track record shows a 0.00% win rate on buys over 90 days with an average return of -20.2%, indicating a pattern of unfavorable timing. The stock is currently down 13.8% from its 52-week high and down 2.4% over 30 days, though up 23.0% over 90 days from an earlier trough.

Director Garrett F L III buys 1,810 shares of FRST at $11.02; prior same-ticker purchase (2024-12-13) declined 20.2% over 90 days.

Director Garrett F L III purchased 1,810 (1.8K shares) of Primis Financial Corp. (FRST) at $11.02 on 2025-08-05, increasing his holdings by 4.4% to 42,979 shares (43.0K shares). His prior purchase at this ticker on 2024-12-13 declined 20.2% over 90 days, and his cross-ticker track record shows 0 of 1 prior buys were well-timed at the 90-day mark, with an average 90d return of -20.2%. The company was unprofitable over its most recent full fiscal year and trades at a P/E of 69.06, significantly elevated relative to fundamentals. The current stock price of $11.05 represents a decline of 13.5% from the 52-week high of $12.78, placing this purchase near the lower end of the recent range but within the context of a director whose prior trades have not recovered over 90-day periods.

Director Garrett F L III buys 3,660 shares of FRST at $12.32; part of 3-insider cluster buy in past 14 days

Director Garrett F L III purchased 3,660 shares at $12.32, increasing his holdings to 41,169 shares (+9.8% vs pre-transaction holdings). This transaction is part of a cluster pattern with 3 other insiders also buying within the past 14 days, which signals coordinated interest at the current valuation. The transaction is notable given that the company reported negative full-year net income over its most recent full fiscal year, yet insiders are accumulating shares near the middle of the 52-week range ($9.55–$13.67). The stock is currently at $12.46, only 1.1% above the transaction price, so the buy occurred at approximately current market levels rather than a significant discount, and the recent 30-day price gain of +2.5% provides context that the stock has been gradually recovering.